No photo of Jesper Breeschoten, van

Jesper van Breeschoten

20212023

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

John B. A. G. Haanen

  • Netherlands Cancer Institute
  • Dutch Institute for Clinical Auditing, Leiden, Netherlands

External person

M. J. Aarts

  • Maastricht University

External person

Ellen H.W. Kapiteijn

  • Leiden University

External person

Christian U. Blank

  • Netherlands Cancer Institute
  • Antoni van Leeuwenhoek Hospital

External person

Marye J. Boers-Sonderen

  • Radboud University Nijmegen

External person

Jan Willem B de Groot

  • Isala Heart Center
  • Isala
  • Oncology Center Isala

External person

Djura Piersma

  • Medisch Spectrum Twente

External person

Geke A P Hospers

  • University Medical Center Groningen
  • University of Groningen

External person

Rawa K. Ismail

  • Scientific department, Leiden, Netherlands
  • Utrecht Institute of Pharmaceutical Sciences
  • Medicines Evaluation Board

External person

Willeke A. M. Blokx

  • Radboud University Medical Center

External person

K. P. M. Suijkerbuijk

  • Utrecht University

External person

Gerard Vreugdenhil

  • Maxima Medical Centre

External person

R. S. van Rijn

  • Medical Centre Leeuwarden

External person

L. C. De Wreede

  • Gemeinnützige GmbH
  • Leiden University Medical Center - LUMC
  • Leiden University Medical Centre
  • Leiden University

External person

Roos S. van Rijn

  • Medical Centre Leeuwarden

External person

Karijn P. M. Suijkerbuijk

  • Utrecht University

External person

Art Vreugdenhil

  • Maxima Medical Centre

External person

Djura P. Piersma

  • Medisch Spectrum Twente (MST)

External person

Olivier J. van Not

  • Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands
  • Utrecht University

External person

Maaike van Dartel

  • Department of Surgical Oncology, Amsterdam, United States

External person

Melissa M. de Meza

  • Leiden University
  • Netherlands Cancer Institute
  • Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands

External person

Anna K.L. Reyners

  • Wageningen University & Research
  • University of Groningen, University Medical Center Groningen
  • University of Groningen

External person

Anthonius de Boer

  • Utrecht University

External person

A. M. G. Pasmooij

  • Medicines Evaluation Board

External person

S. van der Flier

  • Coöperatie VGZ U.A

External person

K. E. Broekman

  • Medicines Evaluation Board
  • University of Groningen

External person

Astrid A. M. van der Veldt

  • Erasmus University Rotterdam

External person

Bert-Jan J. ten Tije

  • Amphia Ziekenhuis

External person

P. de Graeff

  • University of Groningen

External person

Jan W. B. de Groot

  • Departments of Surgery and Medical Oncology, Isala, Zwolle, The Netherlands

External person

Erik W. van Zwet

  • Leiden University Medical Center - LUMC
  • Leiden University Medical Centre
  • Leiden University

External person

Bert-Jan ten Tije

  • Department of Internal Medicine, Breda, Italy

External person

Leonie J. M. Mekenkamp

  • Department of Medical Oncology, 7500 KA Enschede, Netherlands
  • Medisch Spectrum Twente

External person

A. de Boer

  • University of Groningen
  • Utrecht University
  • Erasmus University Rotterdam
  • St Bartholomew's Hospital

External person

Rawa K. Ismail

  • Scientific department, Leiden, Netherlands
  • Utrecht University
  • Medicines Evaluation Board

External person

Ilva Scheerman

  • Utrecht University

External person

Doranne L. Hilarius

  • Department of Pulmonary medicine, Rode Kruis Hospital, Beverwijk, The Netherlands

External person

Liesbeth C. de Wreede

  • Leiden University Medical Centre

External person

Marye J. Boers

  • Radboud University Nijmegen

External person

Valery Lemmens

  • Department of Internal Medicine, Rotterdam, Netherlands
  • Department of Research, Utrecht, Netherlands

External person

Guus M. Bol

  • Utrecht University

External person

Alexander C. van Akkooi

  • Department of Surgical Oncology, 1066 CX Amsterdam, Netherlands

External person

Daan Rauwerdink

  • Leiden University

External person

Cristian U. Blank

  • Netherlands Cancer Institute

External person

Rozemarijn S van Rijn

  • Utrecht University
  • Medical Centre Leeuwarden

External person

Miriam Koopman

  • Utrecht University

External person

Damjan Manevski

  • University of Ljubljana

External person

Caspar van Loosen

  • Dutch Association of Hospital Pharmacists

External person

Rob Kessels

  • Antoni van Leeuwenhoek Hospital

External person

Eva Ellebaek

  • University of Copenhagen

External person

Anna M. G. Pasmooij

  • Department of Psychosocial Oncology and Epidemiology, Amsterdam, United States

External person

M. W.J.M. Wouters

  • Antoni van Leeuwenhoek Hospital
  • Leiden University
  • Netherlands Cancer Institute
  • Dutch Institute for Clinical Auditing
  • Scientific Bureau
  • Netherlands Organisation for Applied Scientific Research

External person

Olga Schuurbiers

  • Radboud University Nijmegen

External person

Marinde J. Bond

  • Utrecht University

External person

Silvia van der Flier

  • Stichting Volksgezondheidszorg (VGZ)

External person

Sietske C. van Nassau

  • Utrecht University

External person

Franz M.N.H. Schramel

  • St. Antonius Ziekenhuis
  • KU Leuven
  • St. Antonius Hospital

External person

Hans J. M. Smit

  • Department of Pulmonary Diseases, 6815 AD Arnhem, Netherlands
  • Rijnstate Hospital

External person

Michiel C. T. van Zeijl

  • Leiden University Medical Centre
  • Dutch Institute for Clinical Auditing, Leiden, Netherlands
  • Leiden University
  • Dutch Institute for Clinical Auditing

External person